Recent advances in the treatment of urinary incontinence in older women

Current Opinion in Urology

Volumn 18, Issue 4, 2008, Pages 383-388

  Wagg, Adrian ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Comorbidity; Older women; Urinary incontinence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLOZAPINE; DARIFENACIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; FESOTERODINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LITHIUM; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; PROPIVERINE; SEROTONIN UPTAKE INHIBITOR; SOLIFENACIN; SPASMOLYTIC AGENT; TOLTERODINE; TROSPIUM CHLORIDE;

AGE DISTRIBUTION; BEHAVIOR MODIFICATION; BLADDER SURGERY; BLADDER TRAINING; COGNITIVE DEFECT; COMORBIDITY; COUNSELING; DRUG FORMULATION; ELDERLY CARE; ELECTROSTIMULATION; EXERCISE; HUMAN; LIFESTYLE; LIFESTYLE MODIFICATION; LOWER URINARY TRACT SYMPTOM; MICTURITION DISORDER; OVERACTIVE BLADDER; PATIENT ASSESSMENT; PELVIC FLOOR MUSCLE TRAINING; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STRESS INCONTINENCE; TREATMENT FAILURE; URINE INCONTINENCE; WOMEN'S HEALTH;

AGE FACTORS; AGED; BOTULINUM TOXINS; COGNITION; EXERCISE; FEMALE; FRAIL ELDERLY; HUMANS; URINARY INCONTINENCE; UROLOGY;

EID: 44649124296     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328302ccc1     Document Type: Review

References (45)

1. Perry S, Shaw C, Assassa P, et al. An epidemiological study to establish the prevalence of urinary symptoms and felt need in the community: the Leicestershire MRC Incontinence Study. J Public Health Med 2000; 22:427-434.
2. Sykes D, Castro R, Pons ME, et al. Characteristics of female outpatients with urinary incontinence participating in a 6-month observational study in 14 European countries. Maturitas 2005; 52 (Suppl 2):13-23.
3. Wagg A, Cohen M. Medical therapy for the overactive bladder in the elderly. Age Ageing 2002; 31:241-246.
4. Rosenberg LJ, Griffiths DJ, Resnick NM. Factors that distinguish continent from incontinent older adults with detrusor overactivity. J Urol 2005; 174:1868-1872.
5. Ko Y, Lin SJ, Salmon JW, Bron MS. The impact of urinary incontinence on quality of life of the elderly. Am J Manag Care 2005; 11:S103-S111.
6. Thom DH, Haan MN, Van Den Eeden SK. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing 1997; 26:367-374.
7. Anpalahan M, Gibson SJ. Geriatric syndromes as predictors of adverse outcomes of hospitalization. Intern Med J 2008; 38:16-23. Examines the wider impact of geriatric syndromes on morbidity and adverse outcomes.
8. Dubeau CE, Simon SE, Morris JN. The effect of urinary incontinence on quality of life in older nursing home residents. J Am Geriatr Soc 2006; 54:1325-1333.
9. Brown JS, McGhan WF, Chokroverty S. Comorbidities associated with overactive bladder. Am J Manag Care 2000; 6 (Suppl 11):S574-S579.
10. Brown JS, Vittinghoff E, Wyman JF, et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 2000; 48:721-725.
11. von Renteln-Kruse W, Krause T. Fall events in geriatric hospital in-patients: results of prospective recording over a 3 year period. Z Gerontol Geriatr 2004; 37:9-14.
12. Gluck T, Wienjes HJ, Rai GS. An evaluation of risk factors for in-patient falls in acute and rehabilitation elderly care wards. Gerontology 1996; 42:104-107.
13. Wagner TH, Hu TW, Bentkover J, et al. Health-related consequences of overactive bladder. Am J Manag Care 2002; 8 (Suppl 19):S598-S607.
14. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50:1306-1314.
15. Kirby M, Artibani W, Cardozo L, et al. Overactive bladder: the importance of new guidance. Int J Clin Pract 2006; 60:1263-1271.
16. Wagg A, Potter J, Peel P, et al. National audit of continence care for older people: management of urinary incontinence. Age Ageing 2008; 37:39-44. The largest comprehensive survey of current trends in care for older people.
17. Coffey A, McCarthy G, McCormack B, et al. Incontinence: assessment, diagnosis, and management in two rehabilitation units for older people. Worldviews Evid Based Nurs 2007; 4:179-186.
18. General household survey; 1998 http://www.archive.officialdocuments.co. uk/document/doh/survey98/. [Accessed 5 April 2008]
19. Kikuchi A, Niu K, Ikeda Y, et al. Association between physical activity and urinary incontinence in a community-based elderly population aged 70 years and over. Eur Urol 2007; 52:868-874. Demonstrates the association of physical exercise and urinary incontinence.
20. Danforth KN, Shah AD, Townsend MK, et al. Physical activity and urinary incontinence among healthy, older women. Obstet Gynecol 2007; 109:721-727.
21. Subak LL, Whitcomb E, Shen H, et al. Weight loss: a novel and effective treatment for urinary incontinence. J Urol 2005; 174:190-195.
22. Kim H, Suzuki T, Yoshida Y, Yoshida H. Effectiveness of multidimensional exercises for the treatment of stress urinary incontinence in elderly community-dwelling Japanese women: a randomized, controlled, crossover trial. J Am Geriatr Soc 2007; 55:1932-1939.
23. van Houten P, Achterberg W, Ribbe M. Urinary incontinence in disabled elderly women: a randomized clinical trial on the effect of training mobility and toileting skills to achieve independent toileting. Gerontology 2007; 53:205-210. An example of interventions for urinary incontinence which do not directly address the lower urinary tract disorder.
24. Bemelmans BL, Kiemeney LA, Debruyne FM. Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects. Eur Urol 2000; 37:709-713.
25. Szonyi G. Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial. Age Ageing 1995; 24:287-291.
26. Ouslander JG, Schnelle JF, Uman G, et al. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo controlled trial. J Am Geriatr Soc 1995; 43:610-617.
27. Gleason DM, Susset J, White C, et al. Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group. Urology 1999; 54:420-423.
28. Dmochowski RR, Davila GW, Zinner NR, et al., for the Transdermal Oxybutynin Study Group. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J Urol 2002; 168:580-586.
29. Chapple C, DuBeau C, Ebinger U, et al. Darifenacin treatment of patients > or = 65 years with overactive bladder: results of a randomized, controlled, 12-week trial. Curr Med Res Opin 2007; 23:2347-2358. A prospective study examining drug therapy for overactive bladder in older women.
30. Hill S, Elhilali M, Millard RJ, et al. Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study. Curr Med Res Opin 2007; 23:2697-2704.
31. Wagg A, Wyndaele J-J, Sieber P. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Am J Geriatr Pharmacother 2006; 4:14-24.
32. Malone-Lee JG, Walsh JB, Maugourd MF. Tolterodine: a safe and effective treatment for older patients with overactive bladder. J Am Geriatr Soc 2001; 49:700-705.
33. Zinner NR, Mattiasson A, Stanton SL. Efficacy, safety and tolerability of extended release once daily tolterodine treatment for overactive bladder in older versus younger patients. J Amer Geriatr Soc 2002; 50:799-807.
34. Dorschner W, Stolzenburg JU, Griebenow R, et al. The elderly patient with urge incontinence or urge-stress incontinence: efficacy and cardiac safety of propiverine. Aktuelle Urol 2003; 34:102-108.
35. Dmochowski RR, Sand PK, Zinner NR, Staskin DR. Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study. Urology 2008; 71:449-454.
36. Chapple C, Van Kerrebroeck P, Tubaro A, et al. Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder. Eur Urol 2007; 52:1204-1212.
37. Katz IR, Sands LP, Bilker W, et al. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc 1998; 46:8-13.
38. Kay G, Crook T, Rekeda L, et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 2006; 50:317-326.
39. Kay G, Kardiasmenos K, Crook T. Differential effects of the antimuscarinic agents tolterodine tartrate ER and oxybutynin chloride ER on recent memory in older subjects. In: Proceedings of the International Continence Society 2006; Christchurch, New Zealand. Poster 87.
40. Schulte-Baukloh H, Weiss C, Stolze T, et al. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 2005; 48:984-990.
41. Shah AD, Kohli N, Rajan SS, Hoyte L. The age distribution, rates, and types of surgery for stress urinary incontinence in the USA. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:89-96.
42. Anger JT, Litwin MS, Wang Q, et al. The effect of age on outcomes of sling surgery for urinary incontinence. J Am Geriatr Soc 2007; 55:1927-1931. Indicates the likely response of older women to surgery for their lower urinary tract dysfunction.
43. Sung VW, Glasgow MA, Wohlrab KJ, Myers DL. Impact of age on preoperative and postoperative urinary incontinence quality of life. Am J Obstet Gynecol 2007; 197:680.e1-680.e5.
44. Campeau L, Tu LM, Lemieux MC, et al. A multicenter, prospective, randomized clinical trial comparing tension-free vaginal tape surgery and no treatment for the management of stress urinary incontinence in elderly women. Neurourol Urodyn 2007; 26:990-994. Demonstrates an improvement in quality of life and stress urinary incontinence for the elderly.
45. Foster RT Sr, Barber MD, Parasio MF, et al. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse. Am J Obstet Gynecol 2007; 197:82.e1-82.e4.